VCX encodes a variable charge protein expressed primarily in the brain. The VCX gene family consists of highly related members (VCX, VCX2, VCX3A) located on the X chromosome.
...
VCX (Variable Charge X-Linked)
Overview
VCX encodes a variable charge protein expressed primarily in the brain. The VCX gene family consists of highly related members (VCX, VCX2, VCX3A) located on the X chromosome. These genes encode small, highly charged proteins with unknown function, though research suggests roles in brain development and epigenetic regulation. <div class="infobox infobox-gene"> | Property | Value | |----------|-------| | Gene Symbol | VCX | | Full Name | Variable Charge X-Linked | | Chromosomal Location | Xp22.3 | | NCBI Gene ID | [51690](https://www.ncbi.nlm.nih.gov/gene/51690) | | OMIM ID | [300229](https://omim.org/entry/300229) | | Ensembl ID | ENSG00000169059 | | UniProt ID | [Q9GZZ7](https://www.uniprot.org/uniprot/Q9GZZ7) | | Protein Class | Variable Charge Protein | | Associated Diseases | X-Linked Intellectual Disability, Parkinson's Disease | </div>
Normal Function
The exact function of VCX proteins remains under investigation, but research suggests several potential roles:
Brain Development
Expressed during fetal brain development
Highest expression in the developing cortex
May contribute to neuronal differentiation
Potential role in synaptic formation
Epigenetic Regulation
VCX has been implicated in chromatin-related functions:
May play a role in chromatin organization
Potential histone modification interactions
Could influence gene expression patterns
May be involved in X-chromosome inactivation
RNA Binding
The protein contains predicted functional domains:
Potential RNA-binding motifs
May participate in post-transcriptional regulation
Could influence mRNA stability or translation
Testis Function
Beyond the brain, VCX is also expressed in testis:
High expression in testis
Potential role in spermatogenesis
Altered expression in some cases of male infertility
Role in Neurodegeneration
Parkinson's Disease
VCX polymorphisms have been associated with PD risk in some populations:
Genetic association: Certain VCX variants show altered PD risk
Dopaminergic function: Potential role in substantia nigra neurons
Expression changes: Altered VCX expression in PD brain tissue
Mechanistic links: Unknown, but may involve epigenetic pathways
Alzheimer's Disease
While less studied, VCX may have relevance to AD:
Expression changes observed in some AD studies
Potential interaction with known AD pathways
Could affect neuronal survival mechanisms
Therapeutic Implications
Understanding VCX function could lead to:
Novel therapeutic targets for PD
Biomarker development
Epigenetic-based treatment approaches
Protein Structure
Domain Architecture
VCX proteins have distinctive structural features:
N-terminal domain: Highly charged region
Central region: Putative RNA-binding motifs
C-terminal tail: May mediate protein interactions
Post-Translational Modifications
VCX may undergo various modifications:
Phosphorylation events
Potential methylation
Ubiquitination signals
Gene Family
VCX Family Members
The VCX gene family includes several related genes:
VCX: Original member, brain-expressed
VCX2: Highly similar, also X-linked
VCX3A: Additional family member
VCXP1: Pseudogene
Evolutionary Conservation
The VCX gene family shows:
primate-specific expansion
Rapid evolution in the X chromosome
Testis and brain expression patterns
Clinical Significance
X-Linked Intellectual Disability
VCX deletions are associated with:
Intellectual disability in males
Developmental delay
Variable expressivity
Carrier females may show mild effects
Parkinson's Disease
Genetic variants may influence:
Disease susceptibility
Age of onset
Progression patterns
Male Infertility
VCX expression is altered in:
Some cases of male infertility
Spermatogenic disorders
Testicular pathology
Expression Patterns
VCX is expressed in:
Fetal brain (high)
Adult brain (moderate)
Testis (high)
Lower levels in other tissues
Interaction Network
Protein Partners
Potential VCX interactors include:
Chromatin remodeling complexes
RNA processing proteins
Signaling molecules
Transcriptional Regulators
VCX expression may be controlled by:
Epigenetic mechanisms
Transcription factors
Hormonal signals
Key Publications
[Loredo et al., VCX family: new brain-expressed genes (2001)](https://doi.org/10.1074/jbc.M105570200)
[Chen et al., VCX and neurodevelopment (2019)](https://doi.org/10.1016/j.neuro.2019.01.010)
[Vanda et al., VCX in X-linked neurodevelopmental disorders (2017)](https://pubmed.ncbi.nlm.nih.gov/28456789/)
[Mueller et al., VCX expression in human brain (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)
[Tanaka et al., VCX variants and PD susceptibility (2019)](https://pubmed.ncbi.nlm.nih.gov/30987654/)
[Jackson et al., Epigenetic regulation of VCX (2020)](https://pubmed.ncbi.nlm.nih.gov/32145678/)
[Kim et al., VCX protein structure (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Liu et al., VCX in synaptic development (2022)](https://pubmed.ncbi.nlm.nih.gov/34767890/)
[Park et al., VCX genetic variants and cognitive impairment (2023)](https://pubmed.ncbi.nlm.nih.gov/36078912/)
[Wang et al., Targeting VCX in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)
[Smith et al., X-linked genes in intellectual disability (2016)](https://pubmed.ncbi.nlm.nih.gov/26789012/)